Coincidence of 20210A prothrombin variant and factor V Leiden predisposing to venous thromboembolism;Współwystȩpowanie wariantu 20210A genu protrombiny i czynnika V Leiden predysponuja̧ce do żylnej choroby zakrzepowo-zatorowej

Polskie Archiwum Medycyny Wewnetrznej

Volumn 102, Issue 6, 1999, Pages 1095-1099

  Adamek, Łukasz ^a   Jankowski, Milosz ^a   Sanak, Marek ^a   Krzanowski, Marek ^a   Grzanka, Piotr ^a   Nizankowska, Ewa ^a   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Deep vein thrombosis; Factor V Leiden; Prothrombin variant 20210A; Pulmonary embolism; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; VEIN THROMBOSIS;

ADULT; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PROTHROMBIN; VENOUS THROMBOSIS;

EID: 0033301955     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Łopaciuk S.: Trombofilia. [w:] Zakrzepy i zatory, PZWL, Warszawa, 1996, 55.
2. Domagala T.B., Undas A., Libura M., Szczeklik A.: Pathogenesis of vascular disease in hyperhomocysteinaemia. Journal of Cardiovascular Risk., 1998, 5, 239.
3. Triplett D.A.: Antiphospolipid-protein antibodies: laboratory detection and clinical relevance. Thrombosis Research, 1995, 78, 1.
4. 2glycoprotein-I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J. Rheumatol., 1997, 24, 1710.
5. Bertina R.M., Koeleman B.P.C., Koster T. i wsp.: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994, 369, 64.
6. Poort S.R., Rosendaal F.R., Reitsma P.H. i wsp.: A common genetic variant in 3'-untranslated region of the protrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood, 1996, 88, 3698.
7. Dahlback B., Carlsson M., Svensson P.J.: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Prediction of a cofactor to activated protein C. Proc. Natl. Acad. Sci. USA, 1993, 90, 1004.
8. Lewandowski K., Rożek M., Turowiecka Z. i wsp.: Złożone defekty hemostazy w rodzinach nosicieli mutacji typu Leiden czynnika V. Pol. Arch. Med. Wewn., 1998, 99, 211.
9. Beauchamp N.J., Dally M.E., Hampton K.K. i wsp.: High prevalence of mutation in factor V gene within UK population relationship to activated protein C resistance and familial thrombosis. Br. J. Haematol., 1994, 88, 219.
10. Mansoor M.A., Srandal A.M., Meland P.M.: Determination of the in vivo redox status of cysteine, cysteinoglycine and glutathione in human plasma. Anal. Biochem., 1992, 200, 218.
11. Torbicki A., Małek G.: Rozpoznawanie żylnej choroby zakrzepowo-zatorowej. [w:] Zakrzepy i zatory, PZWL, 1996, 248.
12. Koster T., Rosendaal F.R., de Roude H. i wsp.: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet, 1993, 342, 1503.
13. Rosendaal F.R., Koster T., Vandenbroucke J.P. i wsp.: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 1995, 85, 1504.
14. Rosendaal F.R., Doggen C.J.M., Zivelin A. i wsp.: Geographic distribution of the 20210G to A prothrombin variant. Thromb. Haemost., 1998, 79, 706.
15. Rees B.C., Liu Y.T., Cox M.J. i wsp.: Factor V Leiden and thermolabile methylentetrahydrofoliate reductase in extreme old age. Thromb. Haemost., 1997, 78, 1357.
16. Cavenach J.D., Colvin B.T.: Guidelines for the management of thrombophilia. Postgraduate Medical Journal, 1996, 72, 87.
17. Hyers T.M., Agnelli G., Hull R.D. i wsp.: Antithrombotic therapy for venous thromboembolic disease. [w:] Fifth ACCP Consensus Conference on Antithrombotic Therapy. Chest, 1998, 114, 5161S.
18. Stefano V.D., Martinelli I., Mannuci P.M. i wsp.: The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and G20210A prothrombin mutation. N. Engl. J. Med., 1999, 341, 801.